Cresco Labs Common Stock Net 2020-2024 | CRLBF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Cresco Labs common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Cresco Labs common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$194.8B
Boston Scientific (BSX)	$139.8B
Stryker (SYK)	$139.4B
EssilorLuxottica (ESLOY)	$110.1B
Medtronic (MDT)	$103.4B
Lonza Group Ag (LZAGY)	$43.7B
Haleon (HLN)	$41.2B
GE HealthCare Technologies (GEHC)	$38.7B
ResMed (RMD)	$34.3B
Terumo (TRUMY)	$28B
Koninklijke Philips (PHG)	$24.3B
Zimmer Biomet Holdings (ZBH)	$20.8B
Insulet (PODD)	$19.1B
Baxter (BAX)	$15B
Smith & Nephew SNATS (SNN)	$10.5B
Bio-Rad Laboratories (BIO)	$9.6B
BellRing Brands (BRBR)	$9.1B
Demant (WILYY)	$8.6B
Lantheus Holdings (LNTH)	$6.7B
Haemonetics (HAE)	$3.9B
ICU Medical (ICUI)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.3B
Envista Holdings (NVST)	$3.2B
QuidelOrtho (QDEL)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
Neogen (NEOG)	$2.7B
GN Store Nord (GNNDY)	$2.6B
LeMaitre Vascular (LMAT)	$2.1B
Green Thumb Industries (GTBIF)	$1.6B